Effect of intravenous nitroglycerin therapy on erythrocyte antioxidant enzymes

References

• Curfman GD, Heinsimer JA, Lozner EC, Fung HL. Intravenous nitroglycerin in the treatment of spontaneous angina pectoris: A prospective, randomized trial. Circulation 1983;67:276–282.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 1988;260:2088–2093.
   Google Scholar
• Sweatman T, Strauss G, Selzer A, Cohn KE. The long-acting hemodynamic effects of isosorbide dinitrate. Am J Cardiol 1972;29:475–480.
   PubMed Web of Science ®Google Scholar
• Ignarro LJ. After 130 years, the molecular mechanism of action of nitroglycerin is revealed. Proc Natl Acad Sci USA 2002;99:7816–7817.
   PubMed Web of Science ®Google Scholar
• Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:39– 49.
   Google Scholar
• Brien JF, McLaughlin BE, Kobus SM, Kawamoto JH, Nakatsu K, Marks GS. Mechanism of glyceryl trinitrate- induced vasodilation. I. Relationship between drug biotrans- formation, tissue cyclic GMP elevation and relaxation of rabbit aorta. J Pharmacol Exp Ther 1988;244:322–327.
   Google Scholar
• Chen Z, Zhang J, Stamler JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA 2002;99:8306–8311.
   PubMed Web of Science ®Google Scholar
• Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Investig 1995;95:187–194.
   Google Scholar
• Schulz E, Tsilimingas N, Rinze R, Reiter B, Wendt M, Oelze M. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circula- tion 2002;105:1170–1175.
   PubMed Web of Science ®Google Scholar
• Wong PS, Eiserich JP, Reddy S, Lopez CL, Cross CE, van der Vliet A. Inactivation of glutathione S-transferases by nitric oxide-derived oxidants: Exploring a role for tyrosine nitration. Arch Biochem Biophys 2001;394:216– 228.
   Google Scholar
• Bassenge E, Fink N, Skatchkov M, Fink B. Dietary supplement with vitamin C prevents nitrate tolerance. J Clin Investig 1998;102:67–71.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance. Circulation 1997;96:2545–2550.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure. Circulation 1998;97:886–891.
   PubMed Web of Science ®Google Scholar
• Beutler E, editor. Red Cell Metabolism: A Manual of Biochemical Methods. 3rd edn. Orlando, FL: Grune & Stratton; 1984.
   Google Scholar
• Zinkham WH. An in vitro abnormality of glutathione metabolism in erythrocytes from normal newborns: Mechan- ism and clinical significance. Pediatrics 1959;23:18–32.
   PubMed Web of Science ®Google Scholar
• Bergmeyer HU, editor. Methods of Enzymatic Analysis, vol. 2 Weinheim, Germany: Verlag Chemie; 1974. p 673–678.
   Google Scholar
• Misra HP, Fridovich IJ. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. Biol Chem 1972;247:3170–3175.
   Web of Science ®Google Scholar
• Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxi- dase. J Lab Clin Med 1967;70:158–169.
   PubMed Web of Science ®Google Scholar
• Bogaert MG. Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations. Clin Pharmacokinet 1987;12:1–11.
   PubMed Web of Science ®Google Scholar
• Bennett BM, Nakatsu K, Brien JF, Marks GS. Biotransform- ation of glyceryl trinitrate to glyceryl dinitrate by human hemoglobin. Can J Physiol Pharmacol 1984;62:704– 706.
   Google Scholar
• Bennett BM, Brien JF, Nakatsu K, Marks GS. Role of hemoglobin in the differential biotransformation of glyceryl trinitrate and isosorbide dinitrate by human erythrocytes. J Pharmacol Exp Ther 1985;234:228–232.
   PubMed Web of Science ®Google Scholar
• Mates JM, Perez-Gomez C, Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999;32:595–603.
   Google Scholar
• Cooper CE. Nitric oxide and iron proteins. Biochim Biophys Acta 1999;1411:290–309.
   PubMed Web of Science ®Google Scholar
• Asahi M, Fujii J, Suzuki K, Seo HG, Kuzuya T, Hori MJ. Inactivation of glutathione peroxidase by nitric oxide. Impli- cation for cytotoxicity. Biol Chem 1995; 270:21035– 21039.
   Google Scholar
• Brown GC. Reversible binding and inhibition of catalase by nitric oxide. Eur J Biochem 1995;232:188–191.
   PubMedGoogle Scholar
• Radi R. Reactions of nitric oxide with metalloproteins. Chem Res Toxicol 1996;9:828–835.
   PubMed Web of Science ®Google Scholar
• Zimrin D, Reichek N, Bogin KT, Aurigemma G, Douglas P, Berko B. Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation 1988;77:1376–1384.
   PubMed Web of Science ®Google Scholar
• Kurz DJ, Naegeli B, Bertel O. A double-blind, randomized study of the effect of immediate intravenous nitroglycerin on the incidence of postprocedural chest pain and minor myocardial necrosis after elective coronary stenting. Am Heart J 2000;139:35–43.
   PubMed Web of Science ®Google Scholar
• Esposito GA, Dunham G, Granger BB, Tudor GE, Granger CB. Converting i.v. nitroglycerin therapy to nitroglycerin ointment therapy: A comparison of two methods. Am J Crit Care 1998;7:123–130.
   Google Scholar